Loading...

Amgen Inc.

AMGNNASDAQ
Healthcare
Drug Manufacturers - General
$279.21
$2.08(0.75%)

Amgen Inc. AMGN Peers

See (AMGN) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - General Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
AMGN$279.21+0.75%150.1B25.43$10.98+3.34%
LLY$779.53+0.53%738.8B63.64$12.25+0.72%
AZN$69.88+0.04%433.3B28.18$2.48+2.21%
JNJ$152.75+0.22%367.4B16.99$8.99+3.31%
ABBV$185.62+1.82%327.8B79.64$2.33+3.45%
NVO$69.02+0.74%305.6B19.02$3.63+2.34%
NVS$121.01+0.83%239B18.97$6.38+3.30%
MRK$79.16+0.08%198.7B11.50$6.88+4.05%
GILD$110.87+0.18%137.9B14.32$7.74+2.83%
PFE$24.24+0.21%137.8B17.57$1.38+7.03%
Showing 1 to 10 of 24 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

AMGN vs LLY Comparison

AMGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMGN stands at 150.1B. In comparison, LLY has a market cap of 738.8B. Regarding current trading prices, AMGN is priced at $279.21, while LLY trades at $779.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMGN currently has a P/E ratio of 25.43, whereas LLY's P/E ratio is 63.64. In terms of profitability, AMGN's ROE is +0.93%, compared to LLY's ROE of +0.77%. Regarding short-term risk, AMGN is less volatile compared to LLY. This indicates potentially lower risk in terms of short-term price fluctuations for AMGN.

Stock Price Comparison

Loading...

Frequently Asked Questions

;